New Developments in Continuous Arteriovenous Hemofiltration/Dialysis

  • Ravindra L. Mehta


There is a growing consensus that continuous renal replacement therapy (1–4) is preferable to intermittent renal replacement in treating patients with acute renal failure (ARF). Continuous therapies are not associated with the rapid “unphysiologic” shifts in fluid and solutes which characterize intermittent hemodialysis (IHD). Conventional IHD utilizes diffusion based transport of solutes and fluid across cellulose acetate and cuprophane membranes. New membranes which use polysulphone, polyacrylonitrile or polyamide as the basic material are more permeable than IHD membranes and have a higher molecular weight cut off for enhanced clearance of middle molecules (5). Alternate renal replacement therapies have evolved with the availability of these membranes (6). Continuous Arteriovenous Hemofiltration/HemoDialysis (CAVH/CAVHD) is a new therapy rapidly gaining acceptance worldwide as the treatment of choice for ARF in critically ill, hemodynamically unstable, patients (7–10). This review describes the current status and discusses new developments of these techniques.


Acute Renal Failure Continuous Renal Replacement Therapy Blood Flow Rate Continuous Therapy Intensive Care Unit Setting 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kramer P, Schrader J, Bohnsack W, Greiden G, Groan HJ, Schaler F: Continuous arteriovenous hemofiltration: A new kidney replacement therapy. Proc Eur Dial Trans Assoc, 18: 743–749, 1981.Google Scholar
  2. 2.
    Lauer A, Sacaggi A, Ronco C, Belledonne M, Glabman S, Bosch JP: Continuous arteriovenous hemofiltration in the critically ill patient Ann Intern Med, 99: 455, 1983.PubMedGoogle Scholar
  3. 3.
    Kaplan AA, Longnecker RE, Folkert VW: Continuous arteriovenous hemofiltration — a report of six months experience. Ann Intern Med, 100: 358, 1984.PubMedGoogle Scholar
  4. 4.
    Weiss L, Danielson BG, Wikstrom B, Hedstrand U, Wahlberg J: Continuous arteriovenous hemofiltration in the treatmnet of 100 critically ill patients with acute renal failure: report on clinical outcome and nutritional aspects. Clin Nephrol, 31: 184–189, 1989.PubMedGoogle Scholar
  5. 5.
    Bosch JP: Continuous arteriovenous hemofiltration (CAVH): Operational characteristics and clinical use. AKF Nephrology, 3, 1986 (Letter).Google Scholar
  6. 6.
    Dickson DM, Hillman KM: Continuous renal replacement in the critically ill. Anesthes Intensiv Care, 18: 76–101, 1990.Google Scholar
  7. 7.
    Schneider NS, Geronemus RP: Continuous arteriovenous hemodialysis. Kidney Int, 5: 159–162, 1988.Google Scholar
  8. 8.
    Gibney RTN, Stollery DE, Lefebvre RE, et al: Continuous arteriovenous hemodialysis: An alternative therapy for acute renal failure associated with critical illness. Can Med Assoc J, 139: 861–866, 1988.Google Scholar
  9. 9.
    Bellomo R, Ernest D, Love J, Parkin G, Boyce N: Continuous arteriovenous hemodiafiltration: optimal therapy for acute renal failure in an intensive care setting? Aust N Zealand J Med, 20: 237–242, 1990.CrossRefGoogle Scholar
  10. 10.
    Bartlett R, Bosch JP, Geronemus RP Paganini EP, Ronco C, Swartz R: Continuous arteriovenous hemo-filtration for acute renal failure: Workshop Summary. Trans Am Soc Art Int Org, 34: 67–77, 1988.Google Scholar
  11. 11.
    Scribner BH, Caner JEZ, Butri R, Quinton W: The technique of continuous hemodialysis. Trans Am Soc Artif Internal Organs, 6: 88–103, 1960.Google Scholar
  12. 12.
    New perspectives in hemodialysis, peritoneal dialysis, arteriovenous hemofiltration and plasmapheresis. Proc Int Symposium, Freiburg, Oct. 1988. Adv Exp Med Biol, 260: 1–213, 1989.Google Scholar
  13. 13.
    Paganini EP: Slow continuous hemofiltration and slow continuous ultrafiltration. Trans Am Soc Art Int Org, 34: 63–66, 1988.Google Scholar
  14. 14.
    Golper TA: Continuous AV hemofiltration in acute renal failure. Am J Kidney Dis, 6: 373–386, 1985.PubMedGoogle Scholar
  15. 15.
    Geronemus R, Schneider N: Continuous arteriovenous hemodialysis: A new modality for the treatment of acute renal failure. Trans Am Soc Art Int Org, 30: 610, 1984.Google Scholar
  16. 16.
    Menta RL, McDonald BR, Aguilar MM, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int, 38: 976–981, 1990.CrossRefGoogle Scholar
  17. 17.
    Wendon J, Smithies M, Sheppard M, Bullen K, Tinker J, Binari D: Continuous high volume venous-venous hemofiltration in acute renal failure, hiten Care Med, 15: 358–363, 1989.Google Scholar
  18. 18.
    Sang YY, Uldall PR, Blake P, Francoeur R, Hall E, Besley M: Continuous veno-venous hemodialysis (CVVHD) in the management of complicated renal failure. J Cannt Spring 18–19, 1990.Google Scholar
  19. 19.
    Freudiger H, Levy M, Suter P, Favre H: Continuous veno-venous hemofiltration in acute renal insufficiency. Nephrologie, 11: 129–133, 1990.PubMedGoogle Scholar
  20. 20.
    Simpson K, Travers M, Allison M: Appropriate renal support in the management of acute renal and respiratory failure: Does early aggressive treatment improve outcome? In: “Current Concepts in Critical Care: Acute Renal Failure in the Intensive Therapy Unit” (Eds D Bihari and G Neild), Springer Verlag, New York, 1990, pp 311–318.Google Scholar
  21. 21.
    Hambroucx R, Bogaert AM, Leroy F, De Vos JY, Larno L: Go-slow dialysis instead of continuous arterio-venous hemofiltration. Intensiv Behandlung, 15:110, 1990.Google Scholar
  22. 22.
    Olbricht CJ, Haubitz H, Habel U, et al: Continuous arteriovenous hemofiltration: In vivo functional characteristics and its dependence on vascular access and filter design Nephron, 55: 49–57, 1990.PubMedCrossRefGoogle Scholar
  23. 23.
    Jenkins R, Fink J, Chen B, Thacker D: Effect of access catheter dimensions on blood flow in CAVH: Intensiv Behandlung, 15: 111, 1990.Google Scholar
  24. 24.
    Ahmad Z: Introduction of percutaneous arteriovenous femoral shunt: A new access for continuous arteriovenous hemofiltration. Am J Kidney Dis, 16: 116–117, 1990.Google Scholar
  25. 25.
    Yohay DA, Schwab SJ, Quarter LD: Parallel plates are more effective than hollow fiber dialysis in continuous arteriovenous hemodialysis (CAVHD). J Am Soc Nephrol, 1: 382, 1990.Google Scholar
  26. 26.
    Vincent HH, Vos MC, deBakkev J, Ahckhauseyn E, van Duyl WA: Continuous A-V hemodiafiltration. Filter design and blood flow rate. Intensiv Behandlung, 15: 113–114, 1990.Google Scholar
  27. 27.
    Ronco C, Brendolan A, Milan M, Feriani M, Chiaramonte S, Bragantini L, La Greca G: Importance of hollow fiber geometry in CAVH. Intensiv Behandlung, 15: 112, 1990.Google Scholar
  28. 28.
    Siegler MH, Teehan BP: Solute transport in continuous hemodialysis: A new treatment for acute renal failure. Kidney Int, 32: 562–571, 1987.CrossRefGoogle Scholar
  29. 29.
    Jenkins RD, Kuhn RJ, Funk JE: Permeability decay in CAVH hemofilters. Trans Am Soc Art Int Org, 34: 590–593, 1988.Google Scholar
  30. 30.
    Schultehis R, Brrings W, Glockner WM, Kierdort H, Sieberth HG: Gravimetric substitution help for controlled cyclic substitution during continuous hemofiltration. Intensiv Behandlung, 15: 112, 1990.Google Scholar
  31. 31.
    Sodemann K, Niedenthal A, Weber C, Schafer GE: Automated fluid balance in continuous hemodialysis (CHD) with blood safety module (BSM) 22. Intensiv Behandlung, 15: 113, 1990.Google Scholar
  32. 32.
    Heinrichs W, Mark S, Fauth U, Halmagyi M: An automatic system for fluid balance in continuous hemofiltration with very high precision. Intensiv Behandlung, 15: 110, 1990.Google Scholar
  33. 33.
    Mason JC: The role of spontaneous and pumped hemofiltration. In: “Acute renal failure in the intensive therapy unit” (Eds D Bihari and G Neild), Springer Verlag, London, 1990, pp 319–329.CrossRefGoogle Scholar
  34. 34.
    Siegler MH, Teehan BP: Continuous arteriovenous hemodialysis. An improved technique for treating acute renal failure in critically ill patients. In: “Clinical Dialysis” (Eds AR Nissenson, RN Fine, DR Gentile) Second Edition, Appleton and Lange, Norwalk Connecticut, 1989, pp 720–734.Google Scholar
  35. 35.
    Golper TA, Leone M: Backtransport of dialysate solutes during in vitro continuous arteriovenous hemodialysis. Blood Purif, 7: 223–229, 1989.PubMedCrossRefGoogle Scholar
  36. 36.
    Kaplan AA: The predilution mode for continuous arteriovenous nemo-filtration. In: “Acute Continuous Renal Replacement Therapy” (Ed E Paganini), Boston, Martinus Nirjhoff, 1986, p 143.CrossRefGoogle Scholar
  37. 37.
    Davies SP, Kox WJ, Brown EA: Clearance studies in patients with acute renal failure treated by continuous arteriovenous haemodialysis. Intensiv Behandlung, 15: 106, 1990.Google Scholar
  38. 38.
    McDonald BR, Menta RL: Transmembrane flux of IL-IB and TNFα in patients undergoing continuous arteriovenous hemodialysis (CAVHD). J Am Soc Nephrol, 1: 368, 1990.Google Scholar
  39. 39.
    Golper TA, Jenkins R, Wright M, Klein JB: Tumor necrosis factor (TNF) and hemofiltration membranes. Intensiv Behandlung, 15: 119, 1990.Google Scholar
  40. 40.
    Bickley SK: Drug dosing during continuous arteriovenous hemofiltration. Clin Pharm, 7: 198–206, 1988.PubMedGoogle Scholar
  41. 41.
    Golper TA, Wedel SK, Kaplan AA, Saad AM, Donata ST, Paganini EP: Drug removal during continuous arteriovenous hemofiltration. Theory and clinical observations. Int J Art Org, 8: 307–312, 1985.Google Scholar
  42. 42.
    Geary JD, Davis G, Raju S: Cyclosporine pharmacokinetics in a lung transplant patient undergoing hemofiltration. Transplantation, 48: 710–712, 1989.Google Scholar
  43. 43.
    Lau A, Kronfol N, Powell S, Adams L: Effect of dialysate flow rate on drug removal by continuous arteriovenous hemodialysis. Am Soc Clin Pharamcol Ther, 45: 161, 1990.Google Scholar
  44. 44.
    Slugg PH, Haug M, Bosworth C, Paganini EP: Comparative vancomycin kinetics in ICU patients with acute renal failure: Intermittent hemodialysis vs continuous hemofiltration/hemodialysis. Intensiv Behandlung, 15: 108, 1990.Google Scholar
  45. 45.
    Reetze R, Bonier J, Keller D, Kohler C, Schollmeyer PJ: ElZination of vancomycin in patients on continuous arteriovenous hemodialysis. Intensiv Behandlung, 15: 108, 1990.Google Scholar
  46. 46.
    Bellomo R, Ernest D, Parker G, Bryce N: Clearance of vancomycin during continuous arteriovenous hemodiafdtration. Crit Care Med, 18: 181–183, 1990.PubMedCrossRefGoogle Scholar
  47. 47.
    Kassum D, Light RB, Brown G, Krohn J, Fine A: Tobramycin clearance during continuous arteriovenous hemofiltration. J Crit Care, 2: 109–111, 1987.CrossRefGoogle Scholar
  48. 48.
    Cigarran-Guldris S, Brier ME, Golper TA: Tobramycin clearance during simulated continuous hemodiafiltration. Intensiv Behandlung, 15: 106, 1990.Google Scholar
  49. 49.
    Weiss LG, Cars O, Danielson BG, Gardner A, Wickstrom B: Pharmacokinetics of intravenous cefuroxime during intermittent and continuous arterio-venous hemofiltration. Clin Nephrol, 30: 282–286, 1988.PubMedGoogle Scholar
  50. 50.
    Przecheva M, Bengel D, Rister T: Pharmacokinetics of imipenem/cilastin during continuous arteriovenous hemofiltration (CAVH). Intensiv Behand, 15: 107–108, 1990.Google Scholar
  51. 51.
    Zusman RM, Rubin RH, Cato AE, Cocchetto BS, Crow JW, Tolkoff-Rubin N: Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med, 304: 934–939, 1981.PubMedCrossRefGoogle Scholar
  52. 52.
    Schrader J, Scheler F: Coagulation disorders in acute renal failure and anticoagulation during CAVH with standard heparin and with low molecular weight heparin. In: “Continuous Arteriovenous Hemofiltration”, Int Conf on CAVH, Aachen Karger, Basel, 1985, pp 25–36.Google Scholar
  53. 53.
    Spinowitz BS: Anticoagulation in continuous arterioveous hemofiltration. In: “Acute Continuous Renal Replacement Therapy”, Proc Third Int Symp, Ft Lauderdale, Florida, 1987, pp 106–110.Google Scholar
  54. 54.
    Ronco C, Brendolan A, Borin D, Bragantini L, Fabris A, Feriane M, Chiaramonte S, La Greca G: Continuous arteriovenous hemofiltration in newborns. In: “Continous Arteriovenous Hemofiltration” (Eds HG Sieberth, H Mann) Karger, Basel, 1985, pp 76–79.Google Scholar
  55. 55.
    King DJ, Kelton JG: Heparin-associated thrombocytopenia. Ann Intern Med, 100: 535, 1984.PubMedGoogle Scholar
  56. 56.
    Schrader J, Stibbe W, Armstrong VW, Kandt M, Muche R, Köstering H, Seidel D, Scheler F: Comparison of low molecular weight heparin to standard heparin in Hemodialysis/hemofiltration. Kidney Int, 33: 890–896, 1988.PubMedCrossRefGoogle Scholar
  57. 57.
    Moriniere P, Dieval J, Bayrou B, Roussel B, Renaud H, Fournier A, Delobel J: Low molecular-weight heparin fraxiparin in chronic hemodialysis. Blood Purif, 7: 301–308, 1989.PubMedCrossRefGoogle Scholar
  58. 58.
    Schrader J, Stibbe W, Kandt M, Warneke G, Armstrong V, Muller HJ, Scheler F: Low molecular weight heparin versus standard heparin: a long-term study in hemodialysis and hemofiltration patients. Trans Am Soc Artif Int Org, 36: 28–32, 1990.Google Scholar
  59. 59.
    Hory B, Cachoux A, Toulemonde F: Continous arteriovenous hemofiltration with low-molecular-weight heparin. Nephron, 42: 125, 1985.CrossRefGoogle Scholar
  60. 60.
    Wynckel A, Bernieh B, Toupance O, N’Guyen Ph. Wopng T, Lavaud s, Chanard J: Guidelines in using enoxaparin in slow continuous hemodialysis. Intensiv Behandlung, 15: 117, 1990.Google Scholar
  61. 61.
    Maher JF, Lapierre L, Schreiner GE, Geiger M, Westervelt FB Jr: Regional heparinisation for hemodialysis. N Engl J Med, 268: 451–456, 1963.CrossRefGoogle Scholar
  62. 62.
    Kaplan AA, Petrillo R: Regional heparinization for continuous arterio-venous hemofiltration. Trans Am Soc Artif Int Org, 33: 312–315, 1987.Google Scholar
  63. 63.
    Schwab SJ, Onorato JJ, Sharar LR, Dennis PA: Hemodilaysis without anticoagulation. One year prospective trial in hospitalized patients at risk for bleeding. Am J Med, 83: 405–410, 1987.PubMedCrossRefGoogle Scholar
  64. 64.
    Sanders PW, Taylor H, Curtis JJ: Hemodialysis without anticoagulation. Am J Kidney Dis, 5: 32–35, 1985.PubMedGoogle Scholar
  65. 65.
    Pinnick RV, Wiegmann TB, Diedrich DA: Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med, 308: 258–263, 1983.PubMedCrossRefGoogle Scholar
  66. 66.
    Von Brecht JH, Flanigan MJ, Freeman RM, Lim VS: Regional anticoagulation: Hemodialysis with hypertonic trisodium citrate. Am J Kidney Dis, 8: 196–201, 1986.Google Scholar
  67. 67.
    Menta RL, McDonald BR, Ward DM: Membrane transfer of citrate and calcium in regional citrate anticoagulation for continuous arteriovenous hemodialysis. J Am Soc Nephrol, 1: 368, 1990.Google Scholar
  68. 68.
    Menta RL, McDonald BR, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis. Intensiv Behandlung, 15: 116, 1990.Google Scholar
  69. 69.
    Gorman RR, Hamilton RD, Hopkins NK: Prostacyclin and thromboxane A2 biosynthesis and regulation of adenylate cyclase in human diploid cell lines. In: “Prostacyclin”, (Eds JR Vane, S Bergstrom), Raven Press, New York, 1979, pp 85–102.Google Scholar
  70. 70.
    Hory B, Saint-Hillier Y, Perol JC: Prostacyclin as the sole antithrombotic agent for acute renal failure hemodialysis. Nephron, 33: 71, 1983.PubMedCrossRefGoogle Scholar
  71. 71.
    Maurin N: Antithrombotic management with a stable prostacyclin analogue during extracorporeal circulation. Intensive Behandlung, 15: 115, 1990.Google Scholar
  72. 72.
    Zobel G, Trop M, Muntean W, Ring E, Gleispach H: Anticoagulation for continuous arteriovenous hemofiltration in children. Blood Purif, 6: 90–95, 1988.PubMedCrossRefGoogle Scholar
  73. 73.
    Stevens PE, Riley B, Davies SP, Gower PE, Brown EA, Kox CW: Continuous arteriovenous hemodialysis in critically ill patients. Lancet, II: 150–152, 1988.CrossRefGoogle Scholar
  74. 74.
    Journois D, Chanu D, Castelain MH: Assessment of standardized ultrafiltrate production rate using prostacyclin (PGI2) in continuous venovenous hemofiltration (CHF). Intensiv Behandlung, 15: 115, 1990.Google Scholar
  75. 75.
    Ponikvar R, Kandus A, Buturovic J, Kveder R et al: Use of prostacyclin as the only anticoagulant during continuous veno venous hemofiltration. Intensive Behandlung, 15: 117, 1990.Google Scholar
  76. 76.
    Ota K, Kawaguchi H, Ito K: A new prostacyclin analogue: an anticoagulant applicable to hemodialysis. Trans Am Soc Art Int Org, 12: 31, 1983.Google Scholar
  77. 77.
    Taenaka N, Terada N, Takahashi H, Tachimori Y et al: Hemodialysis using gebexate mesilate in patients with a high bleeding risk. Crit Care Med, 14: 481–483, 1986.PubMedCrossRefGoogle Scholar
  78. 78.
    Ohtake Y, Hirasawa H, Sugai T, Oda S et al: Nafamostat mesilate (NM) as anticoagulant in continuous hemofiltration (CHF) and continuous hemodiafiltration (CHDF). Intensiv Behandlung, 15: 116, 1990.Google Scholar
  79. 79.
    Costernino F, Paganini E, Lockrem J et al: Continuous arteriovenous hemofiltration (CAVH) in the adult respiratory distress syndrome (ARDS): a randomized controlled trial. Intensiv Behandlung, 15: 103, 1990.Google Scholar
  80. 80.
    Davenport A, Will EJ, Davison AM: Early changes in intracranial pressure during hemofiltration treatment in patients with grade 4 hepatic encephalopathy and acute oliguric renal failure. Nephrol Dial Transpl, 5: 192–198, 1990.Google Scholar
  81. 81.
    Marangoni R, Civardi F, Savino R, Masi F: Continuous arteriovenous hemofiltration (CAVH) improvement by adding diffusion and adsorption. Intensiv Behandlung, 15: 11, 1990.Google Scholar
  82. 82.
    Barzilay E, Kessler D, Lesmet C et al: Sequential plasma filter-dialysis with slow continuous hemofiltration: Additional treatment for sepsis induced ARF patients. J Crit Care, 3: 163–166, 1988.CrossRefGoogle Scholar
  83. 83.
    Golper TA, Ronco C, Kaplan AA: Continuous arterivenous hemofiltration: Improvements, modifications and future directions. Semin Dial, 1: 50–54, 1988.CrossRefGoogle Scholar
  84. 84.
    Raja R, Kramer M, Goldstein S et al: Comparison of continuous arteriovenous hemofiltration and continuous arteriovenous dialysis in critically ill patients. Trans Am Soc Art Int Org, 32: 435–436, 1986.Google Scholar
  85. 85.
    Alarabi AA, Danielson BG, Wikstrom B: Continuous dialysis in acute renal failure. Scand J Urol Nephrol, 24: 1–5, 1990.PubMedCrossRefGoogle Scholar
  86. 86.
    Pattison ME, Lee SM, Ogden DA: Continuous arteriovenous hemodiafiltration: An aggressive approach to the management of acute renal failure. Am J Kidney Dis, 11: 43–47, 1988.PubMedGoogle Scholar
  87. 87.
    Paganini EP: Continuous renal prosthetic therapy in acute renal failure: an overview. Pediatr Clin North Am, 34: 165–185, 1987.PubMedGoogle Scholar
  88. 88.
    Di Carlo JV, Dudley TE, Sherbotie JR, Kaplan BS, Costarino AT: Continuous arteriovenous hemofiltration/dialysis improves pulmonary gas exchange in children with multiple organ system failure. Crit Care Med, 18: 822–826, 1990.CrossRefGoogle Scholar
  89. 89.
    Bishof NA, Welch TR, Frederic Strife C, Ryckman FC: Continuous hemodiafiltration in children. Pediatrics, 85: 819–823, 1990.PubMedGoogle Scholar
  90. 90.
    Zobel G, Ring E, Zobel V: Continuous arteriovenous renal replacement systems for critically ill children. Pediatr Nephrol, 3: 140–143, 1989.PubMedCrossRefGoogle Scholar
  91. 91.
    Heney D, Brocklebank JT, Wilson N: Continuous arteriovenous hemofiltration in the newlyborn with acute renal failure and congenital heart disease. Nephrol Dial Transpl, 4: 870–876, 1989.Google Scholar
  92. 92.
    Speri W, Geiger R, Maurer H, Guggenbichler JP: Continuous arteriovenous hemofiltration in hyperammonaemia of newborn babies. Lancet, 336: 1192–1193, 1990.CrossRefGoogle Scholar
  93. 93.
    Zobel G, Haim M, Ritschl E, Muller W: Continuous arteriovenous hemofiltration as emergency procedure in severe hyperkalemia. Child Nephrol Urol, 9: 236, 1988-89.PubMedGoogle Scholar
  94. 94.
    Bartlett RH, Mault JR, Dechert RE, Palmer J, Swartz RD, Port FK: Continuous arteriovenous hemofiltration: improved survival in surgical acute renal failure. Surgery, 100: 400–408, 1986.PubMedGoogle Scholar
  95. 95.
    Chima C, Heyka R, Meyer L, Bosworth C, Hummel A, Paganini E: Nitrogen balance (NB) in postsurgical patients with acute renal failure on continuous arteriovenous hemofiltration (CAVH) and total parenteral nutriton (TPN). Intensiv Behandlung, 15:97, 1990.Google Scholar
  96. 96.
    McDonald BR, Menta RL, Ward DM: Decreased mortality in patients with acute renal failure (ARF) undergoing continuous arteriovenous hemodialysis (CAVHD) in the intensive care unit (ICU). Intensiv Behandlung, 15: 99, 1990.Google Scholar
  97. 97.
    Kuttnig M, Zobel G, Ring E, Trop M: Parenteral nutrition CAVH in critically ill anuric children. Intensiv Behandlung, 15: 121, 1990.Google Scholar
  98. 98.
    Voerman HI, Strack von Schjindel JM, Thijs LG: Continuous arteriovenous hemodiafiltration in critically ill patients. Crit Care Med, 18: 911–914, 1990.PubMedCrossRefGoogle Scholar
  99. 99.
    Sigler MH, Snyder S, Teehan BP, Benz RL: Amino acid removal during continuous arteriovenous hemodialysis (CAVHD) in patients with acute renal failure (ARF) receiving total parenteral nutrition. Intensiv Behandlung, 15: 100, 1990.Google Scholar
  100. 100.
    Davenport A, Roberts NB: Amino acid losses during continuous high flux hemofiltration in the critically ill patient Crit Care Med, 17: 1010–1014, 1989.PubMedCrossRefGoogle Scholar
  101. 101.
    Cameron JS: Acute renal failure — The continuing challenge. Q J Med, 228: 337–343, 1986.Google Scholar
  102. 102.
    Kjellstrand CM, Etten J, Davis T: Time of death, recovery of renal function, development of chronic renal failure, and need for chronic hemodialysis in patients with acute tubular necrosis. Trans Am Soc Artif Intern Organs, 27: 47–50, 1981.Google Scholar
  103. 103.
    Wilkins RG, Faragher EB: Acute renal failure in an intensive care unit: incidence, predicton and outcome. Anaesthesiology, 38: 638, 1983.Google Scholar
  104. 104.
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system for acutely ill patients. Crit Care Med, 13: 818–829, 1985.PubMedCrossRefGoogle Scholar
  105. 105.
    Dobkin JE, Cutler RE: Use of APACHE II classification to evaluate outcome of patients receiving hemodialysis in an intensive care unit. West J Med, 149: 547–550, 1988.PubMedGoogle Scholar
  106. 106.
    Kohen JA, Whitley KY, and Kjellstrand CM: Continuous arteriovenous hemofiltration: A comparison with hemodialysis in acute renal failure. Trans Am Soc Art Int Org, 31: 169, 1985.Google Scholar
  107. 107.
    Sieberth HG, Kierdorf H: Is continuous haemofiltration superior to intermittent dialysis and hemofiltration treatment? Adv Exp Med Biol, 260: 181–192, 1989.PubMedGoogle Scholar
  108. 108.
    Tarn PY, Huraib S, Mahan B, Le Blanc D, Lunski CA Holtzer C, Doyle CE, Vas SI, Uldall PR: Slow continuous dialysis in the management of complicated acute renal failure in an intensive care unit. Clin Nephrol, 30: 79–85, 1988.Google Scholar
  109. 109.
    Olbricht C, Mueller C, Schurek HJ: Treatment of acute renal failure in patients with multiple organ failure by continuous spontaneous hemofiltration. Trans Am Soc Artif Intern Organs, 28: 33, 1982.PubMedGoogle Scholar
  110. 110.
    Klehr HU, Kascell HJ, Kuchenbecker CH, Munch HG, Spannducker N: Clinical results of continuous arteriovenous hemofiltration. In: “Continuous Arteriovenous Hemofiltration (CAVH)” (Eds HG Sieberth, H Mann) Basel, Switzerland, Karger, 1985, pp 159–165.Google Scholar
  111. 111.
    Domoto DT: Two years experience with continuous arteriovenous hemofiltration in acute renal failure. Trans Am Soc Art Int Org, 31: 581–585, 1985.Google Scholar
  112. 112.
    Frisch S, Kindler J, Schmitter H, Glockner W, Seiberth H: Performance of CAVH in ARF therapy. In: “CAVH” (Eds G La Creca et al) Milan, Wichtig Editore, 1986, pp 283–288.Google Scholar
  113. 113.
    Mault JR, Dechert RE, Lees D, Swartz RD, Port FK, Bartlett RM: Continuous arteriovenous filtration: An effective treatment for surgical acute renal failure. Surgery 101: 478–484, 1987.PubMedGoogle Scholar
  114. 114.
    Lieberman KV: Continuous arteriovenous hemofiltration in children. Pediatr Nephrol, 1: 330–338, 1987.PubMedCrossRefGoogle Scholar
  115. 115.
    Alarabi A, Brendolan A, Danielson BG et al: Outcome of continuous arteriovenous hemofiltration (CAVH) in acute renal failure (ARF): double-centre comparative study. Intensiv Behandlung, 15: 96, 1990.Google Scholar
  116. 116.
    Hirasawa H, Sugai T, Ohtake Y et al: Continuous hemofiltration (CHF) and hemodiafiltration (CHDF) in the management of multiple organ failure (MOF). Intensiv Behandlung, 15: 98, 1990.Google Scholar
  117. 117.
    Schreier P, Keusch G, Binswanger U: Outcome of acute renal failure in critically ill patients treated by continuous hemofiltration. Intensiv Behandlung, 15: 100, 1990.Google Scholar
  118. 118.
    Sluiter HE, Froberg L, van Dijl J, Go G: Mortality in high-risk intensive care patients with acute renal failure treated with CAVH. Intensiv Behandlung, 15: 101, 1990.Google Scholar
  119. 119.
    Zobel G, Ring E, Kuttnig M, Grubbauer HM: CAVH vs CVVH in critically ill pediatric patients. Intensiv Behandlung, 15: 121, 1990.Google Scholar
  120. 120.
    Canaud B, Cristol JP, Berthelemy C, Beraud JJ, Mion C: Acute renal failure (ARF) associated with multiple organ failure (MOF): pump assisted continuous veno-venous hemofiltration (CVVH) the ultimate treatment modality. Intensiv Behandlung, 15: 96, 1990.Google Scholar
  121. 121.
    Korner MM, Banayosy EL, Posival H: Ventricular assist device combined with continuous high volume venous-venous hemofiltration (CWH). Intensiv Behand, 3: 104, 1990.Google Scholar
  122. 122.
    Barzilay E, Wksler N, Kessler D et al: The use of continuous AV hemodialysis in the management of patients with oliguria associated with multiple organ failure. J Int Care Med, 14: 444–445, 1988.CrossRefGoogle Scholar
  123. 123.
    Geronemus RP, Schneider NS, Epstein M: Survival in patients treated with continuous arteiovenous hemodialysis (CAVHD) for acute renal failure (ARF) and chronic renal failure (CRF). Intensiv Behandlung, 15: 97, 1990.Google Scholar
  124. 124.
    Keller E, Reetze P, Bonier J, Lucking FP, Schollmeyer P: Continuous arteriovenous hemodialysis (CAVHD): experience in 18 intensive care patients. Intensiv Behandlung, 15: 98, 1990.Google Scholar
  125. 125.
    Schafer GE, Sodemann K, Doring N, Schroder HM: Continuous arterio-venous (CAVHD) and veno-venous hemodialysis (CWHD) in critically ill patients. Intensive Behandlung 15: 100, 1990.Google Scholar
  126. 126.
    Bastien O, Saroul C, Estanove S: Continuous hemodialysis in acute renal failure following cardiac surgery. Intensiv Behandlung, 15: 101, 1990.Google Scholar

Copyright information

© Springer-Verlag London Limited 1991

Authors and Affiliations

  • Ravindra L. Mehta
    • 1
  1. 1.Division of Nephrology, Department of MedicineUniversity of California San DiegoSan DiegoUSA

Personalised recommendations